.Pharmacolibrary.Drugs.M_MusculoSkeletalSystem.M01A_AntiinflammatoryAndAntirheumaticProductsNonStero.M01AE15_Flunoxaprofen.Flunoxaprofen .Pharmacolibrary.Drugs.M_MusculoSkeletalSystem.M01A_AntiinflammatoryAndAntirheumaticProductsNonStero.M01AE15_Flunoxaprofen.Flunoxaprofen| name: | Flunoxaprofen | |
| ATC code: | M01AE15 | route: | oral |
| compartments: | 1 | |
| dosage: | 100 | mg |
| volume of distribution: | 10 | L |
| clearance: | 0.6 | L/h |
| other parameters in model implementation | ||
Flunoxaprofen is a non-steroidal anti-inflammatory drug (NSAID) of the arylpropionic acid class. It was investigated for treatment of inflammation, pain, and rheumatic conditions. Flunoxaprofen is not currently approved or marketed for clinical use.
No published pharmacokinetic studies are available for flunoxaprofen in humans. The following parameters are estimated based on similarity to other oxaprozin-related NSAIDs (e.g., flurbiprofen, ibuprofen) and standard PK assumptions for this class.